Jaundice and Methamphetamine Use: Understanding Yellow Eyes

Methamphetamine-Induced Jaundice: Mechanism and Significance

Yellowing of the sclera (whites of eyes) and skin—jaundice—in methamphetamine users signals potential liver injury.

Pathophysiology

  1. Direct Hepatotoxicity: Meth and its metabolites cause oxidative stress, mitochondrial dysfunction, and centrilobular necrosis in hepatocytes.
  2. Hyperthermia: Severe agitation → core temp >40°C → hepatic ischemic injury.
  3. Rhabdomyolysis: Muscle breakdown releases myoglobin → acute kidney injury + heme → bilirubin load.
  4. Ischemic Hepatitis: Vasoconstriction + hypotension → "shock liver."
  5. Contaminants/Adulterants: Unknown toxins in illicit supply.
  6. Co-infections: Higher rates of viral hepatitis (B, C) from injection use.

Clinical Presentation

  • Jaundice (bilirubin >2.5 mg/dL visible in sclera).
  • RUQ pain, nausea, dark urine, pale stools.
  • Confusion (hepatic encephalopathy if severe).
  • Signs of multi-organ failure (AKI, coagulopathy, ARDS).

Workup

  • LFTs (AST, ALT, ALP, GGT, bilirubin), INR, albumin, lactate, CK, hepatitis serology, drug screen, imaging (US/CT), consider biopsy.

Management

  • Supportive: Hydration, cooling, correction of electrolytes/acidosis.
  • N-acetylcysteine (NAC) – evidence for non-acetaminophen ALF growing.
  • Treat complications: CRRT, vasopressors, intubation, lactulose/rifaximin for HE.
  • Address addiction: Harm reduction, MAT (no FDA-approved for meth), behavioral therapy.

Prognosis

Acute liver failure from meth carries high mortality (30–50%+). Early recognition and aggressive ICU care are critical. Jaundice in a meth user is a red flag for severe systemic toxicity.

Eye & Vision Disorders - Related Articles